167 results on '"Salas-Alanis, Julio C"'
Search Results
2. CRISPR/Cas9-based targeted genome editing for correction of recessive dystrophic epidermolysis bullosa using iPS cells
3. Physiotherapy for epidermolysis bullosa: clinical practice guidelines
4. Epithelial HMGB1 Delays Skin Wound Healing and Drives Tumor Initiation by Priming Neutrophils for NET Formation
5. Thrombospondin-1 Is a Major Activator of TGF-β Signaling in Recessive Dystrophic Epidermolysis Bullosa Fibroblasts
6. Overexpression of Desmoglein 2 in a Mouse Model of Gorlin Syndrome Enhances Spontaneous Basal Cell Carcinoma Formation through STAT3-Mediated Gli1 Expression
7. Mutations in the Cholesterol Transporter Gene ABCA5 Are Associated with Excessive Hair Overgrowth
8. Sarcoma de Kaposi en región oral y maxilofacial, una neoplasia olvidada
9. Characterization of individuals at high risk of developing melanoma in Latin America: bases for genetic counseling in melanoma
10. Supplementary Data from Identification of Rigosertib for the Treatment of Recessive Dystrophic Epidermolysis Bullosa–Associated Squamous Cell Carcinoma
11. Supplementary Figure 2 from Fibroblast-Derived Dermal Matrix Drives Development of Aggressive Cutaneous Squamous Cell Carcinoma in Patients with Recessive Dystrophic Epidermolysis Bullosa
12. Supplementary Figure 3 from Fibroblast-Derived Dermal Matrix Drives Development of Aggressive Cutaneous Squamous Cell Carcinoma in Patients with Recessive Dystrophic Epidermolysis Bullosa
13. Supplementary Table 1 from Fibroblast-Derived Dermal Matrix Drives Development of Aggressive Cutaneous Squamous Cell Carcinoma in Patients with Recessive Dystrophic Epidermolysis Bullosa
14. Data from Fibroblast-Derived Dermal Matrix Drives Development of Aggressive Cutaneous Squamous Cell Carcinoma in Patients with Recessive Dystrophic Epidermolysis Bullosa
15. Supplementary Methods from Fibroblast-Derived Dermal Matrix Drives Development of Aggressive Cutaneous Squamous Cell Carcinoma in Patients with Recessive Dystrophic Epidermolysis Bullosa
16. Supplementary Figure 4 from Fibroblast-Derived Dermal Matrix Drives Development of Aggressive Cutaneous Squamous Cell Carcinoma in Patients with Recessive Dystrophic Epidermolysis Bullosa
17. Supplementary Table 2 from Fibroblast-Derived Dermal Matrix Drives Development of Aggressive Cutaneous Squamous Cell Carcinoma in Patients with Recessive Dystrophic Epidermolysis Bullosa
18. Supplementary Figure 1 from Fibroblast-Derived Dermal Matrix Drives Development of Aggressive Cutaneous Squamous Cell Carcinoma in Patients with Recessive Dystrophic Epidermolysis Bullosa
19. Bowen's disease
20. Real-time PCR Detection of the Recessive Dystrophic Epidermolysis Bullosa-associated c.2470insG Mutation in Unrelated Mexican Families
21. Keratoderma palmoplantaris varians
22. Mycobacterium abscessus infection associated with mesotherapy injections
23. Secondary syphilis
24. Calcinosis cutis
25. Squamous cell carcinoma of the lower lip
26. Celsus’ Kerion
27. Tattoo-associated HPV-induced verrucae
28. The Role of Tumor Necrosis Factor-α in the Pathogenesis of Vitiligo
29. Multidisciplinary care of epidermolysis bullosa during the COVID-19 pandemic—Consensus: Recommendations by an international panel of experts
30. Hypertrichosis Lanuginosa Congenita Treated with Diode Laser Epilation During Infancy
31. Additional file 1 of Physiotherapy for epidermolysis bullosa: clinical practice guidelines
32. Additional file 3 of Physiotherapy for epidermolysis bullosa: clinical practice guidelines
33. Additional file 4 of Physiotherapy for epidermolysis bullosa: clinical practice guidelines
34. Ancestral patterns of recessive dystrophic epidermolysis bullosa mutations in Hispanic populations suggest sephardic ancestry
35. Patients with Recessive Dystrophic Epidermolysis Bullosa Develop Squamous-Cell Carcinoma Regardless of Type VII Collagen Expression
36. Whole-Transcriptome Analysis by RNA Sequencing for Genetic Diagnosis of Mendelian Skin Disorders in the Context of Consanguinity
37. Identification of C7orf11 (TTDN1) gene mutations and genetic heterogeneity in nonphotosensitive trichothiodystrophy
38. Blastomycosis imported to Monterrey, Mexico: fifth case reported in Mexico
39. Cutaneous adverse effects due to personal protective measures during COVID‐19 pandemic: a study of 101 patients
40. The molecular basis of dystrophic epidermolysis bullosa in Mexico
41. Allelic Heterogeneity of Dominant and Recessive COL7A1 Mutations Underlying Epidermolysis Bullosa Pruriginosa
42. Identification of Rigosertib for the Treatment of Recessive Dystrophic Epidermolysis Bullosa–Associated Squamous Cell Carcinoma
43. Cutaneous adverse effects due to personal protective measures during COVID‐19 pandemic: a study of 101 patients.
44. Epithelial HMGB1 Delays Skin Wound Healing and Drives Tumor Initiation by Priming Neutrophils to NETosis
45. APOBEC mutation drives early-onset squamous cell carcinomas in recessive dystrophic epidermolysis bullosa
46. Omalizumab for hypersensitive reaction to seminal plasma: A case report
47. Preclinical comparison of proteasome and ubiquitin E1 enzyme inhibitors in cutaneous squamous cell carcinoma: The identification of mechanisms of differential sensitivity
48. Innate sensing of microbial products promotes wound-induced skin cancer
49. Heterozygous Mutations in AAGAB Cause Type 1 Punctate Palmoplantar Keratoderma with Evidence for Increased Growth Factor Signaling
50. The Importance of Esophagography in Patients With Recessive Dystrophic Epidermolysis Bullosa
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.